TOPLINE: Sjögren disease (SjD) presents three distinct phenotypes ― B-cell active with low symptom burden, high systemic ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Oncology drugs tend to “percolate to the top” of shortage lists that prioritize drugs of concern, said expert.

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

Artificial intelligence technology has identified many more patients with osteoporosis than institutions can handle.

Loneliness and social isolation have declined since the pandemic but still affect about one third of US adults aged 50-80 ...

Donepezil was associated with improved verbal memory and processing speed compared to placebo in patients with TBI and severe ...

Controlling cardiovascular risk factors and maintaining long-term disease remission mitigated the increased risk for ...

A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have comparable cardiovascular and thrombotic risk profiles as TNF inhibitors.

Neutrophil function was impaired, but glycolysis was unaffected in hospitalized older adults with community-acquired ...

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...